The Cagrilintide family of peptides affects appetite and metabolic rate through amylin receptor agonism
Lifestyle interventions, such as dietary caloric restriction and exercise, currently the cornerstone of therapy for NASH/NAFLD, can be difficult to achieve and maintain, underscoring the dire need for pharmacotherapy
Although weight loss explains part of this effect, studies suggest the relationship between GLP-1 therapy and improved blood pressure control goes deeper
The Downside: What They Dont Tell You Look, lets not sugarcoat reality: GLP-1 receptor agonists come with potential side effects you must know about
Oral semaglutide is a different story entirely, with bioavailability around 1%
Fifty microliters of stop solution was added to each well and the optical density at 450 nm determined using a microtiter plate reader (Liuyi, Beijing, China) within 15 min